Bionovate Technologies Corp. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced operating loss was USD 16,685 compared to USD 2,748 a year ago. Net loss was USD 31,665 compared to USD 24,138 a year ago. For the nine months, operating loss was USD 40,995 compared to USD 27,110 a year ago. Net loss was USD 86,973 compared to USD 99,083 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.